| 查看: 322 | 回复: 3 | |||
| 当前主题已经存档。 | |||
bioinfuture铁虫 (小有名气)
|
[交流]
急需一篇SCI文章,必有金币酬谢
|
||
|
1: Immunol Res. 1998;18(2):79-92.Links The optimization of helper T lymphocyte (HTL) function in vaccine development.Alexander J, Fikes J, Hoffman S, Franke E, Sacci J, Appella E, Chisari FV, Guidotti LG, Chesnut RW, Livingston B, Sette A. Epimmune Inc., San Diego, CA, USA. Helper T lymphocyte (HTL) responses play an important role in the induction of both humoral and cellular immune responses. Therefore, HTL epitopes are likely to be a crucial component of prophylactic and immunotherapeutic vaccines. For this reason, Pan DR helper T cell epitopes (PADRE), engineered to bind most common HLA-DR molecules with high affinity and act as powerful immunogens, were developed. Short linear peptide constructs comprising PADRE and Plasmodium-derived B cell epitopes induced antibody responses comparable to more complex multiple antigen peptides (MAP) constructs in mice. These antibody responses were composed mostly of the IgG subclass, reactive against intact sporozoites, inhibitory of schizont formation in liver invasion assays, and protective against sporozoite challenge in vivo. The PADRE HTL epitope has also been shown to augment the potency of vaccines designed to stimulate a cellular immune response. Using a HBV transgenic murine model, it was found that CTL tolerance was broken by PADRE-CTL epitope lipopeptide, but not by a similar construct containing a conventional HTL epitope. There are a number of prophylactic vaccines that are of limited efficacy, require multiple boosts, and/or confer protection to only a fraction of the immunized population. Also, in the case of virally infected or cancerous cells, new immunotherapeutic vaccines that induce strong cellular immune responses are desirable. Therefore, optimization of HTL function by use of synthetic epitopes such as PADRE or pathogen-derived, broadly crossreactive epitopes holds promise for a new generation of highly efficacious vaccines. |
» 猜你喜欢
计算机、0854电子信息(085401-058412)调剂
已经有5人回复
国自然申请面上模板最新2026版出了吗?
已经有13人回复
基金委咋了?2026年的指南还没有出来?
已经有3人回复
Materials Today Chemistry审稿周期
已经有5人回复
溴的反应液脱色
已经有7人回复
推荐一本书
已经有12人回复
基金申报
已经有4人回复
纳米粒子粒径的测量
已经有7人回复
常年博士招收(双一流,工科)
已经有4人回复
有没有人能给点建议
已经有5人回复
houjinglhy
荣誉版主 (文坛精英)
表达自由,人权之基。
- BioEPI: 1
- 应助: 21 (小学生)
- 贵宾: 0.911
- 金币: 5168.5
- 散金: 3205
- 红花: 137
- 沙发: 93
- 帖子: 10564
- 在线: 912.9小时
- 虫号: 461324
- 注册: 2007-11-18
- 专业: 生物技术药物
- 管辖: 公派出国
★ ★ ★ ★ ★
bioinfuture(金币+5,VIP+0):xiexie 8-21 14:48
bioinfuture(金币+5,VIP+0):xiexie 8-21 14:48

2楼2009-08-21 00:05:18
★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★
bioinfuture(金币+15,VIP+0): 8-21 14:49
bioinfuture(金币+15,VIP+0): 8-21 14:49
| 已发送至你的邮箱shengmingbuxi@yahoo.com.cn。 |
3楼2009-08-21 14:45:41
zhangtangw
木虫 (小有名气)
- 应助: 0 (幼儿园)
- 金币: 3192.7
- 帖子: 106
- 在线: 43.5小时
- 虫号: 586366
- 注册: 2008-08-15
- 性别: GG
- 专业: 食品加工学基础
4楼2009-08-30 16:41:11











回复此楼